The influence of margin width on local control of ductal carcinoma in situ of the breast

New England Journal of Medicine

Volumn 340, Issue 19, 1999, Pages 1455-1461

  Silverstein, Melvin J ^a,b,e   Lagios, Michael D ^c   Groshen, Susan ^a,b   Waisman, James R ^a,b   Lewinsky, Bernard S ^d   Martino, Silvana ^d   Gamagami, Parvis ^d   Colburn, William J ^d  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Kenneth Norris Jr Compreh Cancer   (United States)

^c ST MARY S MEDICAL CENTER   (United States)

^d The Breast Center Inc   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; PRIORITY JOURNAL;

EID: 0033551370     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199905133401902     Document Type: Article

References (39)

1. Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998;16: 441-52.
2. Fisher B, Costantino J, Redmond C, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993;328:1581-6.
3. Lagios MD, Page DL. Radiation therapy for in situ or localized breast cancer. N Engl J Med 1993;329:1577-8.
4. Page DL, Lagios MD. Pathologic analysis of the National Surgical Adjuvant Breast Project (NSABP) B-17 Trial: unanswered questions remaining unanswered considering current concepts of ductal carcinoma in situ. Cancer 1995;75:1219-22.
5. Silverstein MJ, Barth A, Poller DN, et al. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 1995;31:1425-7.
6. Lagios MD, Westdahl PR, Margolin FR, Rose MR. Duct carcinoma in situ: relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 1982;50:1309-14.
7. Lagios MD. Duct carcinoma in situ: pathology and treatment. Surg Clin North Am 1990;70:853-71.
8. Ottesen GL, Graversen HP, Blichert-Toft M, Zedeler K, Andersen JA. Ductal carcinoma in situ of the female breast: short-term results of a prospective nationwide study. Am J Surg Pathol 1992;16:1183-96.
9. Schwartz GF, Finkel GC, Garcia JC, Patchefsky AS. Subclinical ductal carcinoma in situ of the breast: treatment by local excision and surveillance alone. Cancer 1992;70:2468-74.
10. Solin LJ, Yeh IT, Kurtz J, et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation: correlation of pathologic parameters with outcome of treatment. Cancer 1993;71:2532-42.
11. Silverstein MJ, Poller DN, Waisman JR, et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet 1995;345:1154-7.
12. Bellamy COC, McDonald C, Salter DM, Chetty U, Anderson TJ. Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization. Hum Pathol 1993;24:16-23.
13. Zafrani B, Leroyer A, Fourquet A, et al. Mammographically-detected ductal carcinoma in situ of the breast analyzed with a new classification: a study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity. Semin Diagn Pathol 1994;11:208-14.
14. Lagios MD, Margolin FR, Westdahl PR, Rose MR. Mammographically detected duct carcinoma in situ: frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989;63:618-24.
15. Lagios MD. Ductal carcinoma in situ: controversies in diagnosis, biology, and treatment. Breast J 1995;1:68-78.
16. Poller DN, Silverstein MJ, Galea M, et al. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression. Mod Pathol 1994;7:257-62.
17. Fisher ER, Costantino J, Fisher B, Palekar AS, Redmond C, Mamounas E. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17: intraductal carcinoma (ductal carcinoma in situ). Cancer 1995;75:1310-9.
18. Silverstein MJ, Lagios MD, Craig PH, et al. A prognostic index for ductal carcinoma of the breast in situ. Cancer 1996;77:2267-74.
19. Schnitt SJ, Harris JR, Smith BL. Developing a prognostic index for ductal carcinoma in situ of the breast: are we there yet? Cancer 1996;77: 2189-92.
20. Rosai J. Borderline epithelial lesions of the breast. Am J Surg Pathol 1991;15:209-21.
21. Schnitt SJ, Connolly JL, Tavassoli FA, et al. Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol 1992;16:1133-43.
22. Scott MA, Lagios MD, Axelsson K, Rogers LW, Anderson TJ, Page DL. Ductal carcinoma in situ of the breast: reproducibility of histological subtype analysis. Hum Pathol 1997;28:967-73.
23. Douglas-Jones AG, Gupta SK, Attanoos RL, Morgan JM, Mansel RE. A critical appraisal of six modem classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinoma. Histopathology 1996;29:397-409.
24. Bethwaite P, Smith N, Delahunt B, Kenwright D. Reproducibility of new classification schemes for the pathology of ductal carcinoma in situ of the breast. J Clin Pathol 1998;51:450-4.
25. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
26. Miller RG Jr. Survival analysis. New York: John Wiley, 1981.
27. Ashikari R, Hajdu SI, Robbins GF. Intraductal carcinoma of the breast: (1960-1969). Cancer 1971;28:1182-7.
28. Fentiman IS, Fagg N, Millis RR, Hayward JL. In situ ductal carcinoma of the breast: implications of disease pattern and treatment. Eur J Surg Oncol 1986;12:261-6.
29. Bradley SJ, Weaver DW, Bouwman DL. Alternatives in the surgical management of in situ breast cancer: a meta-analysis of outcome. Am Surg 1990;56:428-32.
30. Rosner D, Bedwani RN, Vana J, Baker HW, Murphy GP. Noninvasive breast carcinoma: results of a national survey of the American College of Surgeons. Ann Surg 1980;192:139-47.
31. Solin LJ, Recht A, Fourquet A, et al. Ten-year results of breast-conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast. Cancer 1991;68:2337-44.
32. McCormick B, Rosen PP, Kinne D, Cox L, Yahalom J. Duct carcinoma in situ of the breast: an analysis of local control after conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys 1991;21:289-92.
33. Kuske RR, Bean JM, Garcia DM, et al. Breast conservation therapy for intraductal carcinoma of the breast. Int J Radiat Oncol Biol Phys 1993; 26:391-6.
34. Bornstein BA, Recht A, Connolly JL, et al. Results of treating ductal carcinoma in situ of the breast with conservative surgery and radiation therapy. Cancer 1991;67:7-13.
35. Silverstein MJ, Lagios MD, Martino S, et al. Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast. J Clin Oncol 1998;16:1367-73.
36. Faverly DRG, Burgers L, Bult P, Holland R. Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol 1994;11:193-8.
37. Holland R, Hendriks JHCL, Verbeek ALM, Mravunac M, Schuurmans Stekhoven JH. Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 1990;335:519-22.
38. Holland R, Faverly DRG. Whole-organ studies. In: Silverstein MJ, ed. Ductal carcinoma in situ of the breast. Baltimore: Williams & Wilkins, 1997:233-40.
39. Wolmark N, Dignam J, Fisher B. The addition of tamoxifen to lumpectomy and radiotherapy in the treatment of ductal carcinoma in situ (DCIS): preliminary results of NSABP protocol B-24. Breast Cancer Res Treat 1998;50:227. abstract.